Table 1.
Lactacystin treatment | Inhibition (%) |
---|---|
0 μM (30 min) | 0 |
1 μM (30 min) | 64 |
10 μM (30 min) | 83 |
50 μM (30 min) | 97 |
0 μM (4.5 h) | 0 |
1 μM (4.5 h) | 82 |
10 μM (4.5 h) | >99 |
50 μM (4.5 h) | >99 |
Cells were incubated for 30 min or 4.5 h with different concentrations of the proteasomal inhibitor lactacystin. The cells were homogenized and centrifuged for 10 min at 16,000 × g in the cold, and the supernatants were assayed for proteasomal activity. Proteasomal peptidase activity was measured by monitoring the proteolysis of the fluorogenic proteasomal substrate succinyl-Leu-Leu-Val-Tyr-7-amino-4-methylcoumarin (28). The percent inhibition by each treatment (relative to no treatment) is shown. For the details refer to Experimental Procedures.